Physician

Lakshmi Kant Pathak, MD

According to 2025 Medicare claims, Lakshmi Pathak, MD (NPI: 1467616128) practices nephrology in the Fargo, ND-MN market, with the plurality of this provider's patient population coming from Cass, ND. This provider's primary affiliated billing organization is SANFORD MEDICAL CENTER FARGO (NPI: 1184917924; TIN: 450226909) and primary practice location at 58103-6029. Pathak is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), Collaborative ACO 30, LLC (ACO ID: A5483), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Pathak's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 670 traditional Medicare patients, billed 2,973 HCPCS/CPT codes, and received $199,698 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,920 prescription claims across 360 beneficiaries totaling $239,794 in drug costs, led by Thiola Ec (Tiopronin). DME data shows 481 claims. Open Payments data shows 5 records totaling $93. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $123,571 to $199,698. Similarly, Part D prescription costs have risen steadily, from $19,548 to $239,794. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $1,931 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$114K$228K2015 Medicare payment: $123,571 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $72,529 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $55,943 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $12,001 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $37,205 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $117,876 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $108,365 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $197,278 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $228,338 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $199,698 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156271,525$123,571
2016311974$72,529
2017252761$55,943
2018106192$12,001
2019263408$37,205
20206471,320$117,876
20216701,559$108,365
20225601,530$197,278
20236552,601$228,338
20246702,973$199,698

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$120K$240K2015 Drug cost: $19,548 (USD; Tot_Drug_Cst)2016 Drug cost: $15,291 (USD; Tot_Drug_Cst)2017 Drug cost: $52,087 (USD; Tot_Drug_Cst)2018 Drug cost: $25,099 (USD; Tot_Drug_Cst)2019 Drug cost: $24,975 (USD; Tot_Drug_Cst)2020 Drug cost: $76,263 (USD; Tot_Drug_Cst)2021 Drug cost: $81,025 (USD; Tot_Drug_Cst)2022 Drug cost: $121,023 (USD; Tot_Drug_Cst)2023 Drug cost: $216,042 (USD; Tot_Drug_Cst)2024 Drug cost: $239,794 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015128407$19,548
2016129349$15,291
2017135434$52,087
201880396$25,099
2019163489$24,975
20203621,974$76,263
20213371,876$81,025
20223121,777$121,023
20233731,865$216,042
20243601,920$239,794

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$8.3K$17K2017 Medicare payment: $1,549 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $9,159 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $16,573 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $13,645 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $8,362 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $7,321 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R43$1,549
2018N/RN/RN/R
2019N/RN/RN/R
202033340$9,159
2021N/R345$16,573
202235293$13,645
202343436$8,362
202435481$7,321

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more220264$68
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes139331$58
90935Hemodialysis procedure with physician evaluation87231$53
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more150154$47
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's228256$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Thiola EcTiopronin11330$86,462
FarxigaDapagliflozin Propanediol522,272$40,375
JardianceEmpagliflozin311,870$34,469
Sevelamer CarbonateSevelamer Carbonate351,514$6,811
CalcitriolCalcitriol37224,737$6,546

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodN11154$1,914
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodN1186$1,412
J7507Tacrolimus, immediate release, oral, 1 mgN13141$1,376
J7517Mycophenolate mofetil, oral, 250 mgNN/R49$1,327
J7518Mycophenolic acid, oral, 180 mgNN/R18$1,270

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$93Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Lakshmi Kant Pathak, MD?

Tedicare shows public-source Medicare data for Lakshmi Kant Pathak, MD (NPI 1467616128), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Lakshmi Kant Pathak, MD have ACO affiliation data?

Lakshmi Kant Pathak, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604), Collaborative ACO 30, LLC (MSSP, ACO ID A5483), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Lakshmi Kant Pathak, MD?

Lakshmi Kant Pathak, MD is linked to SANFORD MEDICAL CENTER FARGO (billing NPI 1184917924) in the available physician profile data.

Does Lakshmi Kant Pathak, MD have Open Payments data?

Lakshmi Kant Pathak, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.